Scaling up for the industrial production of rifamycin B; optimization of the process conditions in bench-scale fermentor

Hewaida F. El-Sedawy1, Manal M.M. Hussein2, Tamer Essam1,2, Ossama M. El-Tayeb2, Fatma H.A. Mohammad3
1Microbial Biotechnology Center, Faculty of Pharmacy, Cairo University, Cairo, Egypt
2Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, Egypt
3Microbial Chemical Engineering and Pilot Plant Department, National Research Center, Egypt

Tài liệu tham khảo

Mahalaxmi, 2010, Corn husk as a novel substrate for the production of rifamycin B by isolated Amycolatopsis sp. RSP 3 under SSF, J Process Biochem, 45, 47, 10.1016/j.procbio.2009.08.001 Oppolzer, 1973, Ueber die konstitution und die konfiguration des rifamycin B, O, S and SV, Helv Chim Acta, 56, 2214, 10.1002/hlca.19730560717 Floss, 2005, Rifamycin-mode of action, resistance, and biosynthesis, Chem Rev, 105, 621, 10.1021/cr030112j Sepkowitz, 1995, Tuberculosis in the AIDA era, Clin Microbiol Rev, 8, 180, 10.1128/CMR.8.2.180 Jin, 2004, Scale-up of rifamycin B fermentation with Amycolatopsis mediterranei, J Zhejiang Univ Sci, 5, 1590, 10.1631/jzus.2004.1590 Shuler, 1992 Oosterhuis, 1983, Dissolved oxygen concentration profiles in a production scale bioreactor, J Biotechnol Bioeng, 26, 546, 10.1002/bit.260260522 Ziegler, 1980, Oxygen transfer and mycelial growth in a tubular loop fermentor, J Biotechnol Bioeng, 22, 1613, 10.1002/bit.260220807 Dobson, 2008, The influence of morphology on geldanamycin production in submerged fermentations of Streptomyces hygroscopicus var. geldanus, J Appl Microbiol Biotechnol, 79, 859, 10.1007/s00253-008-1493-3 Mahalaxmi, 2008, Rifamycin B production pattern in Nocardia RSP-3 strain and influence of barbital on antibiotic production, Curr Trends Biotechnol Pharm, 2, 173 Krishna, 1998, Studies on fermentative production of rifamycin using Amycolatopsis mediterranei, World J Microbiol Biotechnol, 14, 689, 10.1023/A:1008801302687 Venkateswarlu, 2000, Improvement of rifamycin B production using mutant strains of Amycolatopsis mediterranei, J Biopro Eng, 23, 315, 10.1007/s004499900068 El-Tayeb, 2004, Optimization of industrial production of rifamycin B by Amycolatopsis mediterranei IV. Production in the fermentor, Afr J Biotechnol, 3, 432, 10.5897/AJB2004.000-2086 El-Tayeb, 2004, Optimization of industrial production of rifamycin B by Amycolatopsis mediterranei II. The role of gene amplification and physiological factors in productivity, Afr J Biotechnol, 3, 273, 10.5897/AJB2004.000-2050 El-Tayeb, 2004, Optimization of industrial production of rifamycin B by Amycolatopsis mediterranei I. The role of colony morphology and nitrogen sources in productivity, Afr J Biotechnol, 3, 266, 10.5897/AJB2004.000-2050 Lancini, 1997, Rifamycins, 521 Lee, 1994, Quantitative analysis of mycelium morphological characteristics and rifamycin B production using Nocardia mediterranei, J Biotechnol, 36, 239, 10.1016/0168-1656(94)90155-4 Sensi, 1967, Production of rifamycins, J Prog Ind Microbiol, 6, 21